View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

Franklin Financial Services Corp: 1 director

A director at Franklin Financial Services Corp bought 2,200 shares at 48.180USD and the significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last...

Fidelity National Information Services Inc: 1 director

A director at Fidelity National Information Services Inc bought 19,846 shares at 50.390USD and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors ov...

 PRESS RELEASE

MacroGenics Reports 2025 Financial Results and Highlights Upcoming Pla...

MacroGenics Reports 2025 Financial Results and Highlights Upcoming Planned Data Disclosures Initial MGC026 (B7-H3 ADC) Phase 1 results in mid-2026Initial MGC028 (ADAM9 ADC) Phase 1 results in second half of 2026Lorigerlimab Phase 2 LINNET study update in mid-2026IND submission for MGC030, a first-in-class TOP1i-based ADC, on track for 3Q 2026Cash, cash equivalents and marketable securities of $189.9 million as of December 31, 2025; cash runway guidance remains into late 2027 ROCKVILLE, Md., March 09, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceu...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: March 7, 2026

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rul...

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) BRISBANE, Calif., March 06, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that, on March 3, 2026, the Compensation Committee of the Board of Directors (Compensation Committee) of Vera Therapeutics granted inducement awards consisting of non-qualified stock options to purchase 46,000 shares of Class A common stock and restricted stock units (RSUs) underlying 25,875 shares of Class A common stock to six (6) new employees under the Vera Therapeutics, Inc. 2024 Inducement Plan ...

 PRESS RELEASE

DAT introduces widget for iPhone to help owner-operators find loads fa...

DAT introduces widget for iPhone to help owner-operators find loads faster PORTLAND, Ore., March 05, 2026 (GLOBE NEWSWIRE) -- DAT Freight & Analytics today introduced the DAT One iOS widget for iPhone, displaying load matches directly on the home screen to help carriers capitalize on real-time rate trends without opening the DAT One app. The DAT One iOS widget refreshes automatically and shows the top three loads with the highest rate per mile based on the most recent search in the DAT One app, providing a competitive edge in a fast-moving freight market. “Owner-operators told us they...

 PRESS RELEASE

Vera Therapeutics Appoints Christopher Hite to Board of Directors

Vera Therapeutics Appoints Christopher Hite to Board of Directors BRISBANE, Calif., March 05, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced the appointment of Christopher Hite, an accomplished executive with decades of corporate and financial strategy leadership experience in the biopharmaceutical sector, to Vera Therapeutics’ Board of Directors. "It is a pleasure to welcome Chris to our Board of Directors at this...

 PRESS RELEASE

Altisource Announces Fourth Quarter and Full Year 2025 Financial Resul...

Altisource Announces Fourth Quarter and Full Year 2025 Financial Results LUXEMBOURG, March 04, 2026 (GLOBE NEWSWIRE) -- Altisource Portfolio Solutions S.A. (“Altisource” or the “Company”) (NASDAQ: ASPS), a leading provider and marketplace for the real estate and mortgage industries, today reported financial results for the fourth quarter and full year 2025. “We are pleased with our full year and fourth quarter 2025 performance driven by disciplined execution, reduced interest expense and strong sales wins. For the year, we grew Service revenue by $10.9 million, or 7%, to $161.3 million, ...

Fidelity National Information Services, Inc.: Update following rating ...

Our credit view of this issuer reflects its leading market positions and its commitment to moderate leverage target, constrained by its intense competition and high capital returns.

 PRESS RELEASE

Lenders One Unites Members and Providers at 2026 Summit, Welcomes New ...

Lenders One Unites Members and Providers at 2026 Summit, Welcomes New President FORT LAUDERDALE, Fla., March 02, 2026 (GLOBE NEWSWIRE) -- Lenders One® Cooperative (“L1” or “Lenders One”), a national mortgage cooperative of independent mortgage bankers, banks and credit unions, today announced the official launch of its 2026 Annual Summit in Fort Lauderdale. The three-day event draws a strong turnout of members and preferred providers in support of the Cooperative’s continued growth and mission: helping its members improve their profitability by reducing costs, maximizing revenue, and shar...

 PRESS RELEASE

Roper Technologies to present at Morgan Stanley technology conference

Roper Technologies to present at Morgan Stanley technology conference SARASOTA, Fla., March 02, 2026 (GLOBE NEWSWIRE) -- Roper Technologies, Inc. (Nasdaq: ROP) announced that it is presenting at the Morgan Stanley Technology, Media & Telecom Conference on Wednesday, March 4, 2026 at 7:45 AM (Pacific Time) in San Francisco, CA. A link to the webcast presentation will be available in the “Investors” section of the Company’s website at . About Roper Technologies Roper Technologies is a constituent of the Nasdaq 100, S&P 500, and Fortune 1000. Roper has a proven, long-term track record of c...

V.F. Corporation - December 2025 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

 PRESS RELEASE

MacroGenics to Participate in Upcoming Investor Conferences

MacroGenics to Participate in Upcoming Investor Conferences ROCKVILLE, MD, Feb. 26, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today announced that the Company’s management team will participate in the following investor conferences in March: TD Cowen 46th Annual Health Care Conference (Boston, MA). MacroGenics’ President and CEO, Eric Risser, will participate in a hybrid presentation and fireside chat on Tuesday, March 3, at 3:10 pm ET. MacroGenics’ manag...

Moody's Ratings affirms FIS's Baa2 senior unsecured ratings; outlook s...

Moody's Ratings (Moody's) affirmed Fidelity National Information Services, Inc.'s ("FIS") senior unsecured notes ratings of Baa2 and Prime-2 commercial paper program ratings. We also assigned Baa2 ratings to the USD and Euro senior unsecured notes (about $8 billion in total) that the company announc...

Laura Chico ... (+2)
  • Laura Chico
  • Thomas Yip
Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch